Vaccinex's Convertible Note Round

Vaccinex raised a round of funding on November 13, 2002.

Vaccinex is a privately held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other targeted biological therapies. A Vaccine…

Articles about Vaccinex's Convertible Note Round: